Skip to main content
PMC home page
Thorax logoLink to Thorax
editorial
. 1994 Nov;49(11):1085–1089. doi: 10.1136/thx.49.11.1085

Tuberculosis in the UK, 1994: current issues and future trends.

L P Ormerod, R J Shaw, D M Mitchell
PMCID: PMC475266  PMID: 7831621

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Annas G. J. Control of tuberculosis--the law and the public's health. N Engl J Med. 1993 Feb 25;328(8):585–588. doi: 10.1056/NEJM199302253280825. [DOI] [PubMed] [Google Scholar]
  2. Babu Swai O., Aluoch J. A., Githui W. A., Thiong'o R., Edwards E. A., Darbyshire J. H., Nunn A. J. Controlled clinical trial of a regimen of two durations for the treatment of isoniazid resistant pulmonary tuberculosis. Tubercle. 1988 Mar;69(1):5–14. doi: 10.1016/0041-3879(88)90035-9. [DOI] [PubMed] [Google Scholar]
  3. Braun M. M., Truman B. I., Maguire B., DiFerdinando G. T., Jr, Wormser G., Broaddus R., Morse D. L. Increasing incidence of tuberculosis in a prison inmate population. Association with HIV infection. JAMA. 1989 Jan 20;261(3):393–397. [PubMed] [Google Scholar]
  4. Brindle R. J., Nunn P. P., Githui W., Allen B. W., Gathua S., Waiyaki P. Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis. Am Rev Respir Dis. 1993 Apr;147(4):958–961. doi: 10.1164/ajrccm/147.4.958. [DOI] [PubMed] [Google Scholar]
  5. Brudney K., Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991 Oct;144(4):745–749. doi: 10.1164/ajrccm/144.4.745. [DOI] [PubMed] [Google Scholar]
  6. Chaisson R. E., Schecter G. F., Theuer C. P., Rutherford G. W., Echenberg D. F., Hopewell P. C. Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis. 1987 Sep;136(3):570–574. doi: 10.1164/ajrccm/136.3.570. [DOI] [PubMed] [Google Scholar]
  7. Chawla P. K., Klapper P. J., Kamholz S. L., Pollack A. H., Heurich A. E. Drug-resistant tuberculosis in an urban population including patients at risk for human immunodeficiency virus infection. Am Rev Respir Dis. 1992 Aug;146(2):280–284. doi: 10.1164/ajrccm/146.2.280. [DOI] [PubMed] [Google Scholar]
  8. Daley C. L., Small P. M., Schecter G. F., Schoolnik G. K., McAdam R. A., Jacobs W. R., Jr, Hopewell P. C. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992 Jan 23;326(4):231–235. doi: 10.1056/NEJM199201233260404. [DOI] [PubMed] [Google Scholar]
  9. Dunlap N., Bailey W. C. A catastrophe is brewing. Chest. 1993 Feb;103(2):332–334. doi: 10.1378/chest.103.2.332. [DOI] [PubMed] [Google Scholar]
  10. Dwyer B., Jackson K., Raios K., Sievers A., Wilshire E., Ross B. DNA restriction fragment analysis to define an extended cluster of tuberculosis in homeless men and their associates. J Infect Dis. 1993 Feb;167(2):490–494. doi: 10.1093/infdis/167.2.490. [DOI] [PubMed] [Google Scholar]
  11. Edlin B. R., Tokars J. I., Grieco M. H., Crawford J. T., Williams J., Sordillo E. M., Ong K. R., Kilburn J. O., Dooley S. W., Castro K. G. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992 Jun 4;326(23):1514–1521. doi: 10.1056/NEJM199206043262302. [DOI] [PubMed] [Google Scholar]
  12. Fischl M. A., Daikos G. L., Uttamchandani R. B., Poblete R. B., Moreno J. N., Reyes R. R., Boota A. M., Thompson L. M., Cleary T. J., Oldham S. A. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med. 1992 Aug 1;117(3):184–190. doi: 10.7326/0003-4819-117-3-184. [DOI] [PubMed] [Google Scholar]
  13. Fischl M. A., Uttamchandani R. B., Daikos G. L., Poblete R. B., Moreno J. N., Reyes R. R., Boota A. M., Thompson L. M., Cleary T. J., Lai S. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992 Aug 1;117(3):177–183. doi: 10.7326/0003-4819-117-3-177. [DOI] [PubMed] [Google Scholar]
  14. FitzGerald J. M., Grzybowski S., Allen E. A. The impact of human immunodeficiency virus infection on tuberculosis and its control. Chest. 1991 Jul;100(1):191–200. doi: 10.1378/chest.100.1.191. [DOI] [PubMed] [Google Scholar]
  15. Foley N. M., Miller R. F. Tuberculosis and AIDS: is the white plague up and coming? J Infect. 1993 Jan;26(1):39–43. doi: 10.1016/0163-4453(93)96776-m. [DOI] [PubMed] [Google Scholar]
  16. Fox W. Compliance of patients and physicians: experience and lessons from tuberculosis-I. Br Med J (Clin Res Ed) 1983 Jul 2;287(6384):33–35. doi: 10.1136/bmj.287.6384.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Frieden T. R., Sterling T., Pablos-Mendez A., Kilburn J. O., Cauthen G. M., Dooley S. W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993 Feb 25;328(8):521–526. doi: 10.1056/NEJM199302253280801. [DOI] [PubMed] [Google Scholar]
  18. Genewein A., Telenti A., Bernasconi C., Mordasini C., Weiss S., Maurer A. M., Rieder H. L., Schopfer K., Bodmer T. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet. 1993 Oct 2;342(8875):841–844. doi: 10.1016/0140-6736(93)92698-s. [DOI] [PubMed] [Google Scholar]
  19. Goble M., Iseman M. D., Madsen L. A., Waite D., Ackerson L., Horsburgh C. R., Jr Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993 Feb 25;328(8):527–532. doi: 10.1056/NEJM199302253280802. [DOI] [PubMed] [Google Scholar]
  20. Hardie R. M., Watson J. M. Screening migrants at risk of tuberculosis. BMJ. 1993 Dec 11;307(6918):1539–1540. doi: 10.1136/bmj.307.6918.1539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Harries A. D. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet. 1990 Feb 17;335(8686):387–390. doi: 10.1016/0140-6736(90)90216-r. [DOI] [PubMed] [Google Scholar]
  22. Helbert M., Robinson D., Buchanan D., Hellyer T., McCarthy M., Brown I., Pinching A. J., Mitchell D. M. Mycobacterial infection in patients infected with the human immunodeficiency virus. Thorax. 1990 Jan;45(1):45–48. doi: 10.1136/thx.45.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hickman M., Ellam T., Hargreaves S., Gazzard B., Porter J. Managing tuberculosis and HIV infection. BMJ. 1992 Jun 13;304(6841):1567–1568. doi: 10.1136/bmj.304.6841.1567-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Iseman M. D., Cohn D. L., Sbarbaro J. A. Directly observed treatment of tuberculosis. We can't afford not to try it. N Engl J Med. 1993 Feb 25;328(8):576–578. doi: 10.1056/NEJM199302253280811. [DOI] [PubMed] [Google Scholar]
  25. Jacobs W. R., Jr, Barletta R. G., Udani R., Chan J., Kalkut G., Sosne G., Kieser T., Sarkis G. J., Hatfull G. F., Bloom B. R. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science. 1993 May 7;260(5109):819–822. doi: 10.1126/science.8484123. [DOI] [PubMed] [Google Scholar]
  26. Long R., Maycher B., Scalcini M., Manfreda J. The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type 1. Chest. 1991 Jan;99(1):123–127. doi: 10.1378/chest.99.1.123. [DOI] [PubMed] [Google Scholar]
  27. Mitchell D. M., Miller R. F. AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease. Thorax. 1992 May;47(5):381–390. doi: 10.1136/thx.47.5.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mitchison D. A., Nunn A. J. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis. 1986 Mar;133(3):423–430. doi: 10.1164/arrd.1986.133.3.423. [DOI] [PubMed] [Google Scholar]
  29. Monie R. D., Hunter A. M., Rocchiccioli K. M., White J. P., Campbell I. A., Kilpatrick G. S. Management of extra-pulmonary tuberculosis (excluding miliary and meningeal) in south and west Wales (1976-8). Br Med J (Clin Res Ed) 1982 Aug 7;285(6339):415–418. doi: 10.1136/bmj.285.6339.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Monie R. D., Hunter A. M., Rocchiccioli K., White J., Campbell I. A., Kilpatrick G. S. Survey of pulmonary tuberculosis in south and west Wales (1976-8). Br Med J (Clin Res Ed) 1982 Feb 20;284(6315):571–573. doi: 10.1136/bmj.284.6315.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ormerod L. P. Drug resistant tuberculosis: problems on the horizon. Thorax. 1993 Oct;48(10):957–958. doi: 10.1136/thx.48.10.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ormerod L. P., Prescott R. J. Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. Respir Med. 1991 May;85(3):239–242. doi: 10.1016/s0954-6111(06)80087-9. [DOI] [PubMed] [Google Scholar]
  33. Ormerod L. P. Results of tuberculosis contact tracing: Blackburn 1982-90. Respir Med. 1993 Feb;87(2):127–131. doi: 10.1016/0954-6111(93)90140-u. [DOI] [PubMed] [Google Scholar]
  34. Ormerod L. P. Tuberculosis screening and prevention in new immigrants 1983-88. Respir Med. 1990 Jul;84(4):269–271. doi: 10.1016/s0954-6111(08)80051-0. [DOI] [PubMed] [Google Scholar]
  35. Packe G. E., Innes J. A. Protective effect of BCG vaccination in infant Asians: a case-control study. Arch Dis Child. 1988 Mar;63(3):277–281. doi: 10.1136/adc.63.3.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pape J. W., Jean S. S., Ho J. L., Hafner A., Johnson W. D., Jr Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet. 1993 Jul 31;342(8866):268–272. doi: 10.1016/0140-6736(93)91817-6. [DOI] [PubMed] [Google Scholar]
  37. Patel K. R. Pulmonary tuberculosis in residents of lodging houses, night shelters and common hostels in Glasgow: a 5-year prospective survey. Br J Dis Chest. 1985 Jan;79(1):60–66. doi: 10.1016/0007-0971(85)90008-7. [DOI] [PubMed] [Google Scholar]
  38. Pearson M. L., Jereb J. A., Frieden T. R., Crawford J. T., Davis B. J., Dooley S. W., Jarvis W. R. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. Ann Intern Med. 1992 Aug 1;117(3):191–196. doi: 10.7326/0003-4819-117-3-191. [DOI] [PubMed] [Google Scholar]
  39. Perriëns J. H., Colebunders R. L., Karahunga C., Willame J. C., Jeugmans J., Kaboto M., Mukadi Y., Pauwels P., Ryder R. W., Prignot J. Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire. Am Rev Respir Dis. 1991 Oct;144(4):750–755. doi: 10.1164/ajrccm/144.4.750. [DOI] [PubMed] [Google Scholar]
  40. Schluger N. W., Rom W. N. Current approaches to the diagnosis of active pulmonary tuberculosis. Am J Respir Crit Care Med. 1994 Jan;149(1):264–267. doi: 10.1164/ajrccm.149.1.8111591. [DOI] [PubMed] [Google Scholar]
  41. Selby C. D., Allen M. B., Leitch A. G. Optimal duration of radiological follow-up for tuberculosis contacts. Respir Med. 1989 Jul;83(4):353–355. doi: 10.1016/s0954-6111(89)80212-4. [DOI] [PubMed] [Google Scholar]
  42. Selwyn P. A., Hartel D., Lewis V. A., Schoenbaum E. E., Vermund S. H., Klein R. S., Walker A. T., Friedland G. H. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989 Mar 2;320(9):545–550. doi: 10.1056/NEJM198903023200901. [DOI] [PubMed] [Google Scholar]
  43. Sheldon C. D., King K., Cock H., Wilkinson P., Barnes N. C. Notification of tuberculosis: how many cases are never reported? Thorax. 1992 Dec;47(12):1015–1018. doi: 10.1136/thx.47.12.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Small P. M., Schecter G. F., Goodman P. C., Sande M. A., Chaisson R. E., Hopewell P. C. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1991 Jan 31;324(5):289–294. doi: 10.1056/NEJM199101313240503. [DOI] [PubMed] [Google Scholar]
  45. Spence D. P., Hotchkiss J., Williams C. S., Davies P. D. Tuberculosis and poverty. BMJ. 1993 Sep 25;307(6907):759–761. doi: 10.1136/bmj.307.6907.759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis. 1993 May;147(5):1311–1320. doi: 10.1164/ajrccm/147.5.1311. [DOI] [PubMed] [Google Scholar]
  47. Sunderam G., McDonald R. J., Maniatis T., Oleske J., Kapila R., Reichman L. B. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA. 1986 Jul 18;256(3):362–366. [PubMed] [Google Scholar]
  48. Sutherland I., Springett V. H. The effects of the scheme for BCG vaccination of schoolchildren in England and Wales and the consequences of discontinuing the scheme at various dates. J Epidemiol Community Health. 1989 Mar;43(1):15–24. doi: 10.1136/jech.43.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Warburton A. R., Jenkins P. A., Waight P. A., Watson J. M. Drug resistance in initial isolates of Mycobacterium tuberculosis in England and Wales, 1982-1991. Commun Dis Rep CDR Rev. 1993 Dec 3;3(13):R175–R179. [PubMed] [Google Scholar]
  50. Wardman A. G., Williams S. E., Curzon P. G., Page R. L., Cooke N. J. Tuberculosis: who should prescribe? Br Med J (Clin Res Ed) 1982 Feb 20;284(6315):569–571. doi: 10.1136/bmj.284.6315.569. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES